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A B S T R A C T
Disseminated infections with hemophagocytic syndrome caused by non-tuberculous mycobacteria
(NTM) are rare. A 60-year-old woman, who presented with fever, chills, anorexia, and right upper
quadrant pain, was admitted to our hospital. Hepatosplenomegaly, pancytopenia, elevated liver
aminotransferases, and hyperferritinemia were noted after admission. A gallium scan and chest
computed tomography revealed multiple mediastinal lymphadenopathy. A bone marrow examination
revealed hemophagocytosis. Bonemarrow and liver biopsies showed non-caseating granulomatosis and
cultures from bone marrow and liver all yielded Mycobacterium kansasii. The patient responded well to
azithromycin, isoniazid, rifampin, and ethambutol. No immunocompromised conditions such as
malignancy, autoimmune disease, or HIV infection were detected initially. However, a right femoral
tumor with pathological fracture was found ﬁve months later during follow-up at the outpatient clinic.
Bone biopsy showed granulocytic sarcoma. To our knowledge, this is the ﬁrst reported case of life-
threatening hemophagocytosis due toM. kansasii. Patients with disseminated NTM infections should be
closely monitored if any immunocompromising condition develops.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
journa l homepage: www.e lsev ier .com/ locate / i j id1. Introduction
Mycobacterium kansasii, a non-tuberculous Mycobacterium
(NTM), is ubiquitous in the environment and widespread in water
and soil.1 In cities, tap water is the common reservoir for M.
kansasii.1 The incidence ofM. kansasii infection has increased over
the past decades, especially in immunocompromised patients such
as thosewith AIDS, organ transplantation,malignancy, chemother-
apy, and dialysis.2,3M. kansasii infectionsmay also occur in healthy
adult and pediatric patients.4 Pulmonary infections and lympha-
denitis are most common, but, rarely, disseminated infection also
occurs.5
Hemophagocytic syndrome (hemophagocytic lymphohistiocy-
tosis) represents a severe hyperinﬂammatory condition with
hypercytokinemia due to a highly stimulated but ineffective
immune response.6 Hemophagocytic syndrome may be primary,
as observed in familial hemophagocytic lymphohistiocytosis,
Chediak–Higashi syndrome, Griscelli syndrome, and X-linked
lymphoproliferative syndrome,6 or secondary, occurring most
commonly in infection. Leading trigger agents are viruses,* Corresponding author. Tel.: +886 2 23123456x66842; fax: +886 2 23971412.
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doi:10.1016/j.ijid.2009.04.017especially the Epstein–Barr virus (EBV) and cytomegalovirus
(CMV).6 Rare cases of Mycobacterium infections triggering
hemophagocytosis have been reported.7–16 Here we report a rare
case of a disseminated NTM infection with life-threatening
hemophagocytic syndrome.
2. Case report
A 60-year-old woman with a 10-year history of hypertension,
with regular control and follow-ups at a local clinic, presented to
our hospital. Ten days before this admission she had suffered from
intermittent fever with chills. She also had a poor appetite,
postprandial nausea, vomiting, and right upper quadrant pain.
There was no productive cough, sore throat, ﬂank pain, or
arthralgia. She denied night sweats or weight loss. No recent
travel history or animal contact history was reported. She was a
cook andwas exposed to tapwater as part of work-related cooking
and cleaning-up. She had taken herbal pills intermittently for
general soreness in the last year.
On arrival at the emergency room, her consciousness was clear
and oriented; her body temperature was 39.2 8C, pulse rate 132/
min, and blood pressure 117/56 mmHg. Tenderness in the right
upper abdominal quadrant with hepatosplenomegaly was
detected. There was no Murphy’s sign or rebound pain. Examina-ses. Published by Elsevier Ltd. All rights reserved.
Figure 2. Histiocytic phagocytosis of erythrocytes and platelets (bone marrow
aspiration, Liu’s stain, 1000  ).
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skin lesion. Abnormal laboratory data included hemoglobin 10.6 g/
dl, white blood cell (WBC) count 2.13  109/l, aspartate transa-
minase 94 IU/l (normal upper limit, 31 IU/l), alanine transaminase
94 IU/l (normal upper limit, 41 IU/l), and g-glutamyl-transpepti-
dase 77 IU/l (normal upper limit, 52 IU/l). A chest ﬁlmwas normal,
however a 12-lead ECG showed sinus tachycardia. A computed
tomography (CT) scan of the abdomen revealed hepatosplenome-
galy. Intravenous cefmetazolewas administered empirically due to
a suspicion of biliary tract infection. However spiking fever was
noted and intravenous cefmetazole was replaced with ceftriaxone
and doxycycline. Nevertheless, her WBC and platelet counts
gradually decreased, and elevated lactic dehydrogenase (1188 U/l;
normal upper limit, 460 U/l), alkaline phosphatase (202 U/l;
normal upper limit, 230 IU/l), and ferritin (up to 8317 ng/ml) were
also noted. Hemophagocytic syndrome was suspected. Virus
proﬁles including HIV, hepatitis B virus, hepatitis C virus, CMV,
EBV, and Cryptococcus antigen, as well as autoimmune proﬁles
were negative. A bone marrow biopsy showed interstitial
lymphohistiocytosis with granulomatous inﬂammation, and
acid-fast stain was negative (Figure 1).
Due to a suspicion of mycobacterial infection, anti-tuberculosis
medications including isoniazid, rifampin, and ethambutol were
prescribed. An enzyme-linked immunosorbent spot (ELISPOT)
assay and TB PCR of bone marrow were all negative. A chest CT
disclosed multiple mediastinal lymphadenopathy. Agranulocyto-
sis with leukocytopenia (white cell count 0.51  109/l), anemia
(hemoglobin, 8.1 g/dl), and thrombocytopenia (platelets 3  109/l)
was noted, accompanied by fever. The bone marrow study was
repeated and a smear showed a few engulfed histiocytes,
compatible with hemophagocytosis (Figure 2). Therefore, intra-
venous immunoglobulin and methylprednisolone 40 mg every
12 hours were given. The fever peak decreased for a short period
but increased later. Bone marrow and liver cultures all yielded M.
kansasii. Thus, disseminated M. kansasii infection was conﬁrmed
and azithromycin was added to the antibiotic regimen of isoniazid,
rifampin, pyrazinamide, and ethambutol. Fever subsided and blood
cell counts gradually increased.
A follow-up chest CT scan showed decreased size of the
mediastinal lymphadenopathy. The patient was discharged three
weeks after initiating anti-tuberculosis therapy. Shewas discharged
with a prescription for anti-mycobacterial medication and with
regular outpatient clinic follow-up. However, right lower thigh pain
was noted ﬁve months following discharge, exacerbated by a fall
from a bicycle. Magnetic resonance imaging (MRI) showed a boneFigure 1. Extensive epithelioid granuloma observed near bone trabecula (bone
marrow biopsy, hematoxylin and eosin Y stain, 400  ).tumor with pathological fracture at the right distal femoral shaft. A
bone biopsy was carried out and granulocytic sarcoma was
conﬁrmed. A thallium-201 tumor scan revealed results compatible
with the MRI and the absence of any other lesion. She received
chemotherapy forgranulocytic sarcomaatouroncologydepartment.
3. Discussion
Hemophagocytic syndrome is an infrequent disorder that is
typically associated with fever and worsening general status,
spleen and liver enlargement with lymphadenopathy, and
involvement of other organs including skin, brain, and lung. Most
reported cases of hemophagocytic syndrome in patients with
mycobacterial infections have been associated with Mycobacter-
ium tuberculosis,9–15 and only three cases have been reported in
patients with NTM infections.7,8,16 A search of the English language
literature for the period 1960–2008 revealed ours to be the ﬁrst
report of disseminated M. kansasii infection with documented
hemophagocytic syndrome.
M. kansasii is a slower growing group and the most virulent of
the NTM. Tap water is thought to be the major reservoir of M.
kansasii in cities. Person-to-person transmission has not been
documented.3 Our patient, a cook with potentially excessive
contact with tap water, might have acquired the infection during
preparation and clean-up. Because the clinical picture and
pathological and acid-fast stain ﬁndings may not be distinguish-
able from tuberculosis, an interferon-g enzyme-linked immuno-
spot assay or tuberculosis DNA PCR can be checked to screen for
the likelihood of tuberculosis. High-performance liquid chroma-
tography (HPLC) analysis of mycolic acid esters can be used if
available to replace colony morphology and pigmentation studies
for the early presumptive identiﬁcation of M. kansasii.17 In our
patient, the results of TB-PCR and ELISPOT were all negative, but
she responded to isoniazid, rifampin, pyrazinamide, and etham-
butol. This situation supports the diagnosis ofM. kansasii infection.
Disseminated infection is rare and cultures from bone marrow,
liver, and other sterile sites are usually necessary for a diagnosis.
Most M. kansasii infections develop in patients who are immuno-
compromised or have an underlying disease. The risk factors forM.
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use of immunosuppressive agents, diabetes, alcoholism, and
hematologic malignancy.1–3 Our patient was eventually found to
have an occult malignancy during follow-up. Therefore, the need
for close follow-up of the host status should be emphasized.
In conclusion, mycobacterial infections associated with hemo-
phagocytic syndrome are rare but should be considered in those
patients where there is associated fever of unknown origin. Early
aggressive survey of the etiology and optimal treatment of the
underlying disease improve the outcome of life-threatening
hemophagocytic syndrome. Bone marrow and liver studies,
including cultures for mycobacterium, are necessary for patients
with fever of unknown origin. Close monitoring of immunocom-
promised conditions such as HIV infection or occult malignancies
in patients with a disseminated NTM infection is emphasized.
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